Skip to main content
LabGenomics. Co., Ltd. logo

LabGenomics. Co., Ltd. — Investor Relations & Filings

Ticker · 084650 ISIN · KR7084650001 KO Human health and social work activities
Open in API
Filings indexed 370 across all filing types
Latest filing 2026-02-06 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 084650

About LabGenomics. Co., Ltd.

http://www.labgenomics.co.kr/

LabGenomics is a biotechnology company specializing in molecular diagnostics and genetic analysis. The company's core activities are structured around three primary areas: diagnostic services, Next-Generation Sequencing (NGS), and the development and manufacturing of in-vitro diagnostic (IVD) products. It provides a comprehensive range of services, including general diagnostics, sample analysis, prenatal malformation testing, and cancer genetic testing. In addition to services, LabGenomics develops and sells diagnostic kits and devices, with a focus on applications for infectious diseases. The company is actively engaged in research and development to create innovative biotechnology products and is pursuing a global expansion strategy, notably through the acquisition of CLIA-certified laboratories to enhance its service capabilities.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including the number of shares and the number of recipients due to employee turnover. This type of filing is a standard regulatory disclosure regarding corporate capital structure and incentive plans, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2026-02-06 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously granted stock options due to employee resignation. In the context of financial filings, reports regarding the issuance or modification of stock options (which affect capital structure and equity) are classified as 'Share Issue/Capital Change' (SHA) as they represent changes to the company's potential share capital and equity-based compensation structure.
2026-02-06 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). This falls under the category of changes in board or management personnel.
2026-01-05 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of 'Regulatory Filings' (RNS) as it is a specific corporate disclosure required by the regulator that does not fit into the more specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2025-12-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients due to employee departures. This type of filing, which concerns changes to capital-related instruments (stock options) and is submitted to regulatory bodies like the Financial Supervisory Service, falls under the category of 'Regulatory Filings' (RNS) as it is a specific corporate disclosure that does not fit into the other specialized categories like DIRS (which is for director/insider trades) or SHA (which is for general share issues).
2025-12-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a correction filing ('정정신고'). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients due to employee departures. This type of disclosure regarding equity compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the Korea Exchange/Financial Supervisory Service that does not fit into more specific categories like DIRS (which is for individual director trades) or SHA (which is for general share issuance).
2025-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.